Drug manufacturers have been cooked on Wednesday for a steep rise in insulin prices, which doubled in the past ninety years
"No one cared or nobody understood that without this next insulin vial I would not have seen another week," said Kristen Whitney Daniels, 28,
She began to rate her insulin after being expelled from her parents' insurance plan two years ago.
"I can not explain how to isolate and how scary," she said. a patient at the Center for Diabetes at Yale University, where a recent study by the American Medical Association magazine found that one in four patients reported "lack of costs." Dr. Kasa Lipskaya treats patients in the clinic and is the main author of the study. She testified on the Capitol Hill last week.
"This bottle of insulin was worth only $ 21
"People die from the lack of access to drugs, which has been around for centuries, and I think it's undeniable," Lipskaya said.
Insulin manufacturers have told CBS News that they have taken steps to address price issues
© 2019 CBS Interactive Inc. All rights reserved.